No Data
No Data
CEO Fan Dong, Jafron Biomedical Co.,Ltd.'s (SZSE:300529) Largest Shareholder Sees Value of Holdings Go Down 3.2% After Recent Drop
Jafron Biomedical: Summary of Half-Year Report in 2024.
Jafron Biomedical: Half-year report for the year 2024.
The Three-year Shareholder Returns and Company Earnings Persist Lower as Jafron BiomedicalLtd (SZSE:300529) Stock Falls a Further 6.7% in Past Week
Jafron Biomedical: 2024 Interim Performance Forecast
Jafron BiomedicalLtd (SZSE:300529) Could Be Struggling To Allocate Capital
No Data